NEUROFIBROMATOSIS 1 (NF1)
Clinical trials for NEUROFIBROMATOSIS 1 (NF1) explained in plain language.
Never miss a new study
Get alerted when new NEUROFIBROMATOSIS 1 (NF1) trials appear
Sign up with your email to follow new studies for NEUROFIBROMATOSIS 1 (NF1), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for NF1 patients: drug shows promise against inoperable tumors
Disease control OngoingThis study tests a drug called selumetinib in adults with neurofibromatosis type 1 (NF1) who have nerve tumors that cannot be removed by surgery. The goal is to see if the drug can shrink these tumors or slow their growth. Participants take the drug twice daily and are monitored …
Matched conditions: NEUROFIBROMATOSIS 1 (NF1)
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Laser zaps NF1 skin bumps in small trial
Symptom relief TerminatedThis study tests whether monthly alexandrite laser treatments can safely shrink or improve the look of skin tumors in adults with neurofibromatosis type 1 (NF1). Ten participants will receive up to six monthly laser sessions, with some areas treated with cooling and others withou…
Matched conditions: NEUROFIBROMATOSIS 1 (NF1)
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC